Toronto — Predictmedix AI Inc. (CSE: PMED | OTC: PMEDF | FRA: 3QP), a leader in artificial intelligence-powered health screening, has launched a mobile platform aimed at revolutionizing diabetes diagnostics in India. The new solution delivers instant, non-invasive diabetic risk assessments using only a smartphone, signaling the company’s expansion into the direct-to-consumer healthcare market.
Leveraging proprietary AI technology, the platform analyzes facial and biometric data to provide real-time feedback on a user’s risk of diabetes, without requiring blood tests, clinical visits, or lab infrastructure. With over 100 million diagnosed diabetics in India and many more undiagnosed, the company sees this tool as a vital resource for improving access to early screening in a country facing a mounting public health crisis.
“We are addressing a critical gap in healthcare access with a cutting-edge solution that empowers individuals to take control of their health using the device they already own — their mobile phone,” said Dr. Rahul Kushwah, COO of Predictmedix AI. “India has over 100 million diabetics and a significant number remain undiagnosed. Our app is designed to bridge that diagnostic divide.”
The app features a user-friendly interface with multilingual support and is fully compliant with India’s Digital Personal Data Protection (DPDP) Act, ensuring secure and private data handling. By combining smartphone accessibility with cloud-based delivery, Predictmedix AI is aiming for rapid scale and global reach with minimal marginal cost.
India’s smartphone adoption now exceeds 1.1 billion users, creating an unprecedented opportunity for mobile-first, AI-driven health solutions. Predictmedix AI believes its platform is uniquely positioned to capture significant market share in this high-need, high-growth environment while supporting public health initiatives led by governments, NGOs, and large employers.
The mobile diabetes screening platform is a cornerstone of Predictmedix AI’s broader mission to reshape global healthcare delivery through scalable, preventative, and AI-powered technology.
